Anugerah 88 Logo
$14.99+0.04|(+0.27%)
52W H: 24.2752W L: 12.409Beta: 0.62

About Avalo Therapeutics Inc

Frequently Asked Questions

What is the 52-week range for AVTX?

The 52-week high is $24.27 and the 52-week low is $12.409.

What is the P/E ratio for AVTX?

The P/E ratio data is currently unavailable.

What is the dividend yield for AVTX?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -58.03%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -23254.24%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 3.97.

Analyst Recommendation Trends

Wall Street analyst consensus for AVTX over the last few months:

2026-09-01
Buy: 10
S.Buy: 10
Hold: 1
Sell: 0
2026-08-01
Buy: 10
S.Buy: 10
Hold: 1
Sell: 0
2026-07-01
Buy: 10
S.Buy: 9
Hold: 1
Sell: 0
2026-06-01
Buy: 10
S.Buy: 8
Hold: 1
Sell: 0

Latest AVTX News

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

WAYNE, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to three new employees. The Compensation Committee of the Board of Directors of Avalo approved the grants of nonstatutory stock options to purchase an aggregate of 101,600 shares of common stock (the “Options”)

Yahoo9/29/2026

Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress

WAYNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced a late-breaker oral presentation and poster at the upcoming EADV Congress 2026, to be held in Vienna, Austria from September 30-October 3, 2026. EADV Congress 2026 Presentation Details: Late-Breaker Oral Presentation: Title: Efficacy and Safety of A

Yahoo9/23/2026

Avalo Therapeutics To Present Abdakibart Data At EADV Congress 2026

Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced a late-breaker

Benzinga9/23/2026

Avalo Therapeutics: Phase 2 Validation Has Created An IL-1β Franchise

Avalo Therapeutics (AVTX) is now a well-funded, registrational-stage biotech with validated Phase II data for abdakibart in hidradenitis suppurativa (HS).

SeekingAlpha9/4/2026

Related Stocks (Peers)

Companies operating in similar sectors to AVTX:

GLUERIGLSANAOBXARDXAVTXANNXCADLDSGNGERN950160.KQ

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-30Philip Ron M+1,109$12.29$13,630
2026-09-30Jain Rita+1,322$12.29$16,247
2026-09-30Lind Kevin Robert+1,352$12.29$16,616
2026-09-16Sullivan Christopher Ryan-12,394--
2026-09-16Sullivan Christopher Ryan-12,394$16.3335$202,437
2026-09-16Sullivan Christopher Ryan+12,394$9.88$122,453
2026-09-10Sullivan Christopher Ryan-10,185--
2026-09-10Sullivan Christopher Ryan-10,185$17.6197$179,457
2026-09-10Sullivan Christopher Ryan+10,185$8.04$81,887
2026-08-28Doyle Mittie-679--
2026-08-28Doyle Mittie-679$20$13,580
2026-08-28Doyle Mittie+679$8.04$5,459
2026-08-18Sullivan Christopher Ryan-31,031--
2026-08-18Sullivan Christopher Ryan-31,031$20.0549$622,324
2026-08-18Sullivan Christopher Ryan+31,031$9.88$306,586
2026-08-17Doyle Mittie-1,000--
2026-08-17Doyle Mittie-1,000$20$20,000
2026-08-17Doyle Mittie+1,000$12.65$12,650
2026-08-17Sullivan Christopher Ryan-2,876--
2026-08-17Sullivan Christopher Ryan-37,945--
2026-08-17Sullivan Christopher Ryan-3,749$19.9419$74,762
2026-08-17Sullivan Christopher Ryan-37,945$19.8533$753,333
2026-08-17Sullivan Christopher Ryan+2,876$9.88$28,415
2026-08-17Sullivan Christopher Ryan+37,945$9.88$374,897
2026-08-11Riley Jennifer-2,655$19.5903$52,012
2026-08-10Doyle Mittie-679--
2026-08-10Doyle Mittie-679$20$13,580
2026-08-10Doyle Mittie+679$8.04$5,459
2026-07-27Doyle Mittie-1,000--
2026-07-27Doyle Mittie-1,000$20$20,000
2026-07-27Doyle Mittie+1,000$12.65$12,650
2026-06-30Philip Ron M+69$15.04$1,038
2026-06-30Doyle Mittie-1,779--
2026-06-30Doyle Mittie-2,875--
2026-06-30Doyle Mittie-4,654$20$93,080
2026-06-30Doyle Mittie+1,779$8.04$14,303
2026-06-30Doyle Mittie+2,875$12.65$36,369
2026-06-30Jain Rita+1,080$15.04$16,243
2026-06-30Lind Kevin Robert+1,105$15.04$16,619
2026-06-23Philip Ron M+40,200--
2026-06-23Doyle Mittie-1,450--
2026-06-23Doyle Mittie-1,450$18$26,100
2026-06-23Doyle Mittie+1,450$8.04$11,658
2026-06-10Riley Jennifer-588$13.1$7,703
2026-06-10Doyle Mittie-1,084$13.1$14,200
2026-06-10Sullivan Christopher Ryan-138$13.1$1,808
2026-06-10VARKI PAUL-1,081$13.1$14,161
2026-06-02Truex Samantha+20,100--
2026-06-02KANTOFF AARON+20,100--
2026-06-02Jain Rita+20,100--
2026-06-02Lind Kevin Robert+20,100--
2026-06-02Heffernan Michael Thomas+29,500--
2026-06-02KAPLAN GILLA+20,100--
2026-05-28Doyle Mittie-679--
2026-05-28Doyle Mittie-679$16$10,864
2026-05-28Doyle Mittie+679$8.04$5,459
2026-05-21Riley Jennifer+34,200--
2026-05-21Doyle Mittie+43,500--
2026-05-21Sullivan Christopher Ryan+39,900--
2026-05-21VARKI PAUL+24,300--
2026-05-21NEIL GARRY ARTHUR+100,200--
2026-05-15Doyle Mittie-3,000--
2026-05-15Doyle Mittie-3,000$18.76$56,280
2026-05-15Doyle Mittie+3,000$12.65$37,950
2026-05-07Sullivan Christopher Ryan-18,606--
2026-05-07Sullivan Christopher Ryan-18,606$24.1222$448,818
2026-05-07Sullivan Christopher Ryan+18,606$9.88$183,827
2026-05-06Doyle Mittie-28,650--
2026-05-06Doyle Mittie-77,905--
2026-05-06Doyle Mittie-10,058$22.88$230,127
2026-05-06Doyle Mittie-19,015$22.406$426,050
2026-05-06Doyle Mittie-44,944$21.1968$952,669
2026-05-06Doyle Mittie-5,000$19.6502$98,251
2026-05-06Doyle Mittie-27,538$18.0262$496,405
2026-05-06Doyle Mittie+28,650$8.04$230,346
2026-05-06Doyle Mittie+77,905$12.65$985,498
2026-05-06Sullivan Christopher Ryan-47,000--
2026-05-06Sullivan Christopher Ryan-8,900$22.5745$200,913
2026-05-06Sullivan Christopher Ryan-9,219$21.3698$197,008
2026-05-06Sullivan Christopher Ryan-2,700$20.76$56,052
2026-05-06Sullivan Christopher Ryan-12,347$19.2835$238,093
2026-05-06Sullivan Christopher Ryan-13,834$18.5525$256,655
2026-05-06Sullivan Christopher Ryan+47,000$8.04$377,880
2026-05-06VARKI PAUL-12,563--
2026-05-06VARKI PAUL-62,500--
2026-05-06VARKI PAUL-400$23.71$9,484
2026-05-06VARKI PAUL-9,253$22.6985$210,029
2026-05-06VARKI PAUL-22,839$21.2155$484,541
2026-05-06VARKI PAUL-5,196$19.7812$102,783
2026-05-06VARKI PAUL-37,375$18.912$706,836
2026-05-06VARKI PAUL+12,563$8.04$101,007
2026-05-06VARKI PAUL+62,500$13.43$839,375
2026-05-06Chan Mitchell-3,167$22.88$72,461
2026-05-05Doyle Mittie-679--
2026-05-05Doyle Mittie-1,000--
2026-05-05Doyle Mittie-1,679$16$26,864
2026-05-05Doyle Mittie+679$8.04$5,459
2026-05-05Doyle Mittie+1,000$12.65$12,650
2026-04-30Sullivan Christopher Ryan-8,457$13.2261$111,853
2026-04-29Sullivan Christopher Ryan-8,458$13.0925$110,736
2026-04-06Doyle Mittie-3,970--
2026-04-06Doyle Mittie-3,970$18.0122$71,508
2026-04-06Doyle Mittie+3,970$12.65$50,221
2026-04-02Sullivan Christopher Ryan-1,780$17.5674$31,270
2026-04-02Sullivan Christopher Ryan-6,200$17.0247$105,553
2026-04-01Doyle Mittie-679--
2026-04-01Doyle Mittie-679$16$10,864
2026-04-01Doyle Mittie+679$8.04$5,459
2026-04-01Sullivan Christopher Ryan-7,479$16.8259$125,841
2026-04-01Sullivan Christopher Ryan-500$15.858$7,929
2026-03-31Jain Rita+1,339$12.13$16,242
2026-03-31Lind Kevin Robert+1,370$12.13$16,618
2026-03-28Goldman Jonathan-3,166--
2026-03-28Goldman Jonathan+3,166--
2026-03-28Sullivan Christopher Ryan-24,200--
2026-03-28Sullivan Christopher Ryan-8,241$13.89$114,467
2026-03-28Sullivan Christopher Ryan+24,200--
2026-03-28Chan Mitchell-3,166--
2026-03-28Chan Mitchell+3,166--
2026-03-28Truex Samantha-3,166--
2026-03-28Truex Samantha+3,166--
2026-03-28KANTOFF AARON-3,166--
2026-03-28KANTOFF AARON+3,166--
2026-03-28NEIL GARRY ARTHUR-64,866--
2026-03-28NEIL GARRY ARTHUR-21,892$13.89$304,080
2026-03-28NEIL GARRY ARTHUR+64,866--
2026-03-28KAPLAN GILLA-3,166--
2026-03-28KAPLAN GILLA+3,166--
2026-03-16Doyle Mittie-5,992--
2026-03-16Doyle Mittie-19,500--
2026-03-16Doyle Mittie-25,492$16.1465$411,607
2026-03-16Doyle Mittie+5,992$8.04$48,176
2026-03-16Doyle Mittie+19,500$12.65$246,675
2026-02-26Boyd Taylor+95,000--
2026-02-26Riley Jennifer+95,000--
2026-02-26Doyle Mittie+105,000--
2026-02-26Sullivan Christopher Ryan+105,000--
2026-02-26VARKI PAUL+80,000--
2026-02-26NEIL GARRY ARTHUR+286,000--
2025-12-31Lind Kevin Robert+848$14.74$12,500
2025-12-31Jain Rita+1,043$14.74$15,374
2025-12-10Doyle Mittie-1,013$4.1$4,153
2025-12-10Riley Jennifer-637$4.1$2,612
2025-12-10VARKI PAUL-1,016$4.1$4,166
2025-12-10Sullivan Christopher Ryan-155$4.1$636
2025-11-14Goldman Jonathan-8,200--
2025-11-14Goldman Jonathan-8,200$14.3474$117,649
2025-11-14Goldman Jonathan+8,200$9.88$81,016
2025-11-14Goldman Jonathan-3,167$14.3$45,288